State of Wisconsin Investment Board
CARM

State of Wisconsin Investment Board’s Carisma Therapeutics CARM Stock Holding History

State of Wisconsin Investment Board’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,055
Closed -$175K – 2163
2021
Q3 		$175K Hold
11,055
– – ﹤0.01% 2082
2021
Q2 		$1.02M Buy
+11,055
New +$705K ﹤0.01% 1442

Other funds holding CARM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State of Wisconsin Investment Board's CARM Position: Q4 2021 in Review

State of Wisconsin Investment Board sold out of Carisma Therapeutics (CARM) in Q4 2021, closing a stake of 11,055 shares — an estimated $175K sold.

State of Wisconsin Investment Board first reported a position in CARM in Q2 2021 and held it in 2 quarters. The position peaked at $1.02M in Q2 2021. 93 funds tracked by Wall St. Rank hold CARM as of Q4 2021.

  • State of Wisconsin Investment Board reported no remaining Carisma Therapeutics position as of Q4 2021 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 11,055 Carisma Therapeutics shares in Q4 2021, an estimated $175K.
  • State of Wisconsin Investment Board first reported a position in Carisma Therapeutics in Q2 2021 and held it in 2 quarters.
  • State of Wisconsin Investment Board's Carisma Therapeutics position peaked at $1.02M in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q4 2021.

Based on State of Wisconsin Investment Board's 13F filing for Q4 2021, filed 11 Feb 2022.